These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 27161173)
1. The ever-changing landscape of pancreatic cancer stem cells. Sancho P; Alcala S; Usachov V; Hermann PC; Sainz B Pancreatology; 2016; 16(4):489-96. PubMed ID: 27161173 [TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer stem cells: A state or an entity? Hermann PC; Sainz B Semin Cancer Biol; 2018 Dec; 53():223-231. PubMed ID: 30130664 [TBL] [Abstract][Full Text] [Related]
4. Fetal bovine serum enlarges the size of human pancreatic cancer spheres accompanied by an increase in the expression of cancer stem cell markers. Sasaki N; Toyoda M; Hasegawa F; Fujiwara M; Gomi F; Ishiwata T Biochem Biophys Res Commun; 2019 Jun; 514(1):112-117. PubMed ID: 31027735 [TBL] [Abstract][Full Text] [Related]
5. Influence of interferon-α on the expression of the cancer stem cell markers in pancreatic carcinoma cells. Zhu Y; Karakhanova S; Huang X; Deng SP; Werner J; Bazhin AV Exp Cell Res; 2014 Jun; 324(2):146-56. PubMed ID: 24726912 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer stem cells--insights and perspectives. Hermann PC; Mueller MT; Heeschen C Expert Opin Biol Ther; 2009 Oct; 9(10):1271-8. PubMed ID: 19723015 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer stem cells: regulatory networks in the tumor microenvironment and targeted therapy. Takao S; Ding Q; Matsubara S J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):614-20. PubMed ID: 22878838 [TBL] [Abstract][Full Text] [Related]
9. Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies. Lonardo E; Cioffi M; Sancho P; Crusz S; Heeschen C J Vis Exp; 2015 Jun; (100):e52801. PubMed ID: 26132091 [TBL] [Abstract][Full Text] [Related]
10. Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells. Dalla Pozza E; Dando I; Biondani G; Brandi J; Costanzo C; Zoratti E; Fassan M; Boschi F; Melisi D; Cecconi D; Scupoli MT; Scarpa A; Palmieri M Int J Oncol; 2015 Mar; 46(3):1099-108. PubMed ID: 25502497 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma. Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992 [TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer stem cell markers and exosomes - the incentive push. Heiler S; Wang Z; Zöller M World J Gastroenterol; 2016 Jul; 22(26):5971-6007. PubMed ID: 27468191 [TBL] [Abstract][Full Text] [Related]
13. Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells. Valle S; Alcalá S; Martin-Hijano L; Cabezas-Sáinz P; Navarro D; Muñoz ER; Yuste L; Tiwary K; Walter K; Ruiz-Cañas L; Alonso-Nocelo M; Rubiolo JA; González-Arnay E; Heeschen C; Garcia-Bermejo L; Hermann PC; Sánchez L; Sancho P; Fernández-Moreno MÁ; Sainz B Nat Commun; 2020 Oct; 11(1):5265. PubMed ID: 33067432 [TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer stem cells: new insight into a stubborn disease. Zhan HX; Xu JW; Wu D; Zhang TP; Hu SY Cancer Lett; 2015 Feb; 357(2):429-37. PubMed ID: 25499079 [TBL] [Abstract][Full Text] [Related]
15. JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells. Recio-Boiles A; Ilmer M; Rhea PR; Kettlun C; Heinemann ML; Ruetering J; Vykoukal J; Alt E Oncotarget; 2016 Mar; 7(9):9890-906. PubMed ID: 26840266 [TBL] [Abstract][Full Text] [Related]
16. DNMT1 Inhibition Reprograms Pancreatic Cancer Stem Cells via Upregulation of the miR-17-92 Cluster. Zagorac S; Alcala S; Fernandez Bayon G; Bou Kheir T; Schoenhals M; González-Neira A; Fernandez Fraga M; Aicher A; Heeschen C; Sainz B Cancer Res; 2016 Aug; 76(15):4546-58. PubMed ID: 27261509 [TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways. Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243 [TBL] [Abstract][Full Text] [Related]
18. FoxO1-negative cells are cancer stem-like cells in pancreatic ductal adenocarcinoma. Song W; Li Q; Wang L; Huang W; Wang L Sci Rep; 2015 Jun; 5():10081. PubMed ID: 26068418 [TBL] [Abstract][Full Text] [Related]
19. Visualization of stem cell activity in pancreatic cancer expansion by direct lineage tracing with live imaging. Maruno T; Fukuda A; Goto N; Tsuda M; Ikuta K; Hiramatsu Y; Ogawa S; Nakanishi Y; Yamaga Y; Yoshioka T; Takaori K; Uemoto S; Saur D; Chiba T; Seno H Elife; 2021 Jan; 10():. PubMed ID: 33393460 [TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinoma. Vizio B; Mauri FA; Prati A; Trivedi P; Giacobino A; Novarino A; Satolli MA; Ciuffreda L; Camandona M; Gasparri G; Bellone G Oncol Rep; 2012 Jan; 27(1):69-76. PubMed ID: 21922151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]